Study Finds Least Fit Need More Exercise

The people with the most to gain from exercise may need to do more of it, not less, to unlock the same protection against cardiovascular disease.

That is the sharp conclusion from new research drawing on data from more than 17,000 British adults in the UK Biobank study. Researchers measured baseline cardiorespiratory fitness with a cycle test, using estimated VO2 max, then tracked participants’ typical activity with a wearable device over a week. Their analysis suggests that adults with the lowest fitness levels need roughly 30 to 50 more minutes of exercise each week than the fittest adults to achieve a similar reduction in cardiovascular risk.

The finding lands with force because it appears to push against a familiar public health message: that the least fit people can make big gains from relatively small changes. This study does not argue that exercise fails for those people. It argues something narrower, and more unsettling. Starting fitness level may shape how much activity a person needs before the cardiovascular payoff starts to resemble the benefit seen in fitter peers.

That distinction matters. Public health advice often aims for simple targets that large numbers of people can understand and follow. But the real world rarely works so neatly. Bodies do not respond in identical ways, and baseline fitness may act as a powerful filter on how exercise translates into measurable risk reduction. If that holds up, it would mean a one-size-fits-all prescription tells only part of the story.

Why the findings are already under scrutiny

The study’s headline result has not gone unchallenged. Reports indicate some experts have criticized aspects of the work and called parts of it misguided. That reaction matters almost as much as the result itself. Research on exercise and cardiovascular risk sits at the intersection of epidemiology, physiology, and public guidance. Small choices in how scientists measure fitness, categorize activity, or model risk can reshape the headline conclusion in ways that sound decisive but rest on contested assumptions.

Those concerns do not erase the study’s value. They do, however, place it where it belongs: as part of an argument, not the final word. UK Biobank offers a huge and powerful dataset, and wearable trackers give researchers a better view of actual movement than self-reported questionnaires alone. Still, observational analysis cannot settle every question about cause and effect. It can reveal patterns. It cannot by itself prove exactly why those patterns appear, or whether they apply equally across age groups, health conditions, and daily routines.

The study does not say exercise matters less for the least fit; it suggests they may need a bigger weekly dose to reach the same cardiovascular payoff.

Even so, the signal cuts through because it reflects a stubborn reality about fitness: people do not begin from the same place. A brisk walk can feel easy for one person and punishing for another. The same number of minutes on a tracker may represent very different biological strain. That makes any comparison between “minutes exercised” and “benefit received” more complicated than standard recommendations imply. In that sense, the study taps into an intuition many clinicians and patients already recognize from lived experience.

For readers trying to make practical sense of the news, the clearest takeaway remains simple. This is not an argument to give up if you are currently unfit. It is an argument against assuming that universal exercise targets produce universal outcomes. If further research supports the finding, it could strengthen the case for more tailored advice that considers baseline fitness, not just age, weight, or broad activity bands. The goal would not change: reduce cardiovascular risk. The route there might need to become more individual.

What comes next for exercise guidance

The next step will likely involve deeper analysis and sharper debate. Researchers will need to test whether the result holds in other populations, with different methods of measuring fitness and activity, and across longer periods of follow-up. Experts will also want to know whether the extra 30 to 50 minutes reflects a true biological difference or a feature of how the study modeled risk. Until that work arrives, readers should treat the finding as important but provisional.

Long term, the stakes reach beyond one study. Health systems and public campaigns rely on clear, scalable advice, but precision matters when millions of people use that advice to make daily decisions. If baseline fitness truly changes the amount of exercise needed for comparable heart benefits, future guidance may shift from broad minimums toward more personalized targets. That would not make exercise advice more confusing by necessity. Done well, it could make that advice more honest, more useful, and more effective for the people who need it most.